BioCatalyst

ONC — BeOne Medicines Ltd. catalysts

2 verified catalyst event(s) for BeOne Medicines Ltd. (ticker ONC). Each is linked to its official source. Verified as of 2026-11-04.

Next verified catalyst

2026-12-31 — A Study to Evaluate Long-term Safety of Zanubrutinib Regimens in Participants With B-Cell · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-31
in 2mo
ESTIMATED
 READOUT
A Study to Evaluate Long-term Safety of Zanubrutinib Regimens in Participants Wi
Phase 3 · B-cell Malignancies
 ONC BeOne Medicines Ltd. Zanubrutinib, Tislelizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participant
Phase 1/2 · B-cell Malignancy, Marginal Zone Lymphoma
 ONC BeOne Medicines Ltd. Tacabrutideg ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.